Peptide laws in Brazil
Last updated: October 3, 2026 · 4 min read · By the Grey Peptides Editorial Board
- On July 2, 2026, ANVISA said GHK-Cu, BPC-157, TB-500, CJC-1295 and ipamorelin are not registered in Brazil in any category and are illegal for any health or aesthetic use.
- In Brazil, food supplements can only be taken by mouth, and there are no injectable cosmetics, so an injectable peptide cannot be legal as either.
- Compounding requires an individual prescription, a licensed pharmacy and a substance that has passed efficacy and safety analysis.
- Approved peptide medicines such as semaglutide and tirzepatide are regularised products, prescribed for their approved uses.
How Brazil regulates peptides
Brazil's Agência Nacional de Vigilância Sanitária, ANVISA, regulates medicines, foods and supplements, and cosmetics. A product sold for health use must be regularised in one of those categories. ANVISA's July 2026 clarification explains how peptides sold online fail each test 1.
ANVISA's July 2026 clarification
On July 2, 2026, ANVISA published a fact-check stating that some injectable peptides are not regularised with the agency in any category, food, medicine, cosmetic or food supplement, and are therefore illegal for any health use, including aesthetic use, and offer no guarantee of safety, origin or composition 1. It named products presented as GHK-Cu, BPC-157, TB-500, CJC-1295 and ipamorelin, promoted for effects such as collagen production, faster healing and muscle recovery, as not registered 1.
It set out why, category by category 1:
- Food supplements: substances such as BPC-157 and TB-500 are not authorised as supplement ingredients, and no company has applied or submitted studies to add them to the permitted list under Normative Instruction 28/2018. No supplement in Brazil may be injectable; the category is limited to oral use.
- Medicines: the named peptides are not registered. Medicines must show safety and efficacy, including in clinical studies, and any substance to be compounded must have passed efficacy and safety analysis.
- Compounding: a formula may only be compounded individually, on a medical prescription, by a pharmacy licensed with local health surveillance.
- Cosmetics: there are no injectable cosmetics; a product offered that way is an irregular cosmetic.
ANVISA contrasted these with insulin and with semaglutide and tirzepatide, which it described as properly regularised medicines that passed extensive studies before approval 1.
Compounded GLP-1 drugs
Trade press reported that in April 2026 ANVISA opened discussion of a normative instruction to regulate imports of GLP-1 and GLP-1/GIP active ingredients for compounding, with requirements including a good manufacturing practice certificate, minimum quality-control testing in Brazil and pharmacovigilance in pharmacies 2. We have not read the draft itself and do not describe its final status. The July clarification's compounding rules, an individual prescription and a licensed pharmacy, apply regardless 1.
Brazil and the US debate
Brazilian coverage has contrasted ANVISA's position with the FDA advisory committee's July 2026 votes on BPC-157 and other peptides for US compounding 2. A US advisory vote does not change Brazilian law: ANVISA's July 2 statement stands on its own terms 1. Our PCAC hub explains what the US votes do and do not mean.
Buying online and importing
ANVISA's clarification says the named peptides are illegal for any health use and offer no guarantee of origin or composition 1. We did not read a primary ANVISA source on personal import of peptides for this page, so we do not state import rules. For prescribed medicines carried while travelling, keep them in original packaging with the prescription.
Sport
Brazilian athletes follow the WADA Prohibited List. BPC-157 is prohibited under S0, and growth hormone secretagogues and releasing peptides, including ipamorelin, are named under S2.2.4 3. Our WADA hub lists each peptide.
Questions to check
- Is the product an ANVISA-registered medicine, prescribed for its approved use?
- Is it injectable but sold as a supplement or cosmetic? In Brazil that is irregular by definition.
- If compounded, is there an individual prescription and a licensed pharmacy?
- Am I subject to anti-doping rules?
The bottom line
Brazil's position is unusually explicit. ANVISA stated on July 2, 2026 that GHK-Cu, BPC-157, TB-500, CJC-1295 and ipamorelin are not registered in any category and are illegal for any health or aesthetic use, that supplements cannot be injectable and that injectable cosmetics do not exist. Approved peptide medicines such as semaglutide and tirzepatide remain prescription products.
Frequently asked questions
Are peptides legal in Brazil?
Registered peptide medicines are legal on prescription. ANVISA stated in July 2026 that GHK-Cu, BPC-157, TB-500, CJC-1295 and ipamorelin are not registered in any category and are illegal for any health or aesthetic use.
Is BPC-157 legal in Brazil?
No. ANVISA says it is not registered as a medicine, supplement or cosmetic. It is also prohibited in sport under WADA's S0.
Can a Brazilian pharmacy compound BPC-157?
ANVISA says any substance to be compounded must have passed efficacy and safety analysis, and compounding requires an individual prescription and a licensed pharmacy.
Can peptides be sold as supplements in Brazil?
Not injectable ones. Brazilian supplements are limited to oral use, and BPC-157 and TB-500 are not authorised supplement ingredients.
Related on Grey Peptides
Sources
- ANVISA. Checamos: peptídeos que prometem milagres NÃO estão registrados na Anvisa. Published July 2, 2026; read October 3, 2026. Source
- ICTQ (Brazilian pharmacy trade press). Reports on ANVISA's April 2026 consultation on GLP-1/GIP active-ingredient imports for compounding and on the July 2026 clarification. Read October 3, 2026.
- Grey Peptides WADA hub (2026 Prohibited List). Read October 3, 2026.
Educational information, not medical advice. Each dose in this guide names its source, an approved label or a published study. None is a recommendation for you. An unapproved compound has no established safe or effective human dose, and products sold for “research use only” are not made or tested for people. Talk to a doctor before acting on anything on this site, including before you start, stop or change any medicine or dose.
New guides and rule changes, by email
One short email when a peptide's legal status moves — an FDA or PCAC decision, a WADA list change, an enforcement action — plus new guides and tools. At most one a week, and none when nothing changes. The newsletter has not started sending yet: your first email will be its first issue.
We keep your email address and the page you signed up from, nothing else. How it works · Privacy · RSS instead